Resources Contact Us Home Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE     Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety Image Number 13 for United States Patent #8119616. The present invention relates to a composition comprising an inclusion complex of a cyclodextrin and quinazoline containing zinc-binding moiety based derivatives. The cyclodextrin is preferable a .beta.-cyclodextrin or a derivative thereof. The quinazolines have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and their use in the treatment of EGFR-TK related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.       Recently Added Patents Display comprising a plurality of substrates and a plurality of display materials disposed between the plurality of substrates that are connected to a plurality of non-overlapping integral con Mobile authorization using policy based access control Beverage bag Method for vehicle internetworks System and method for observing communication behavior Vacuum sealing appliance Semiconductor memory device, method of controlling read preamble signal thereof, and data transmission system   Randomly Featured Patents Plating bath and method Stainless steel sheet for a gasket Method and communication network for administering subscriber data, particularly service data Tape guide System debug and trace system and method, and applications thereof Thiazolidinedione derivatives as hypoglycemic agents Combination ceiling fan and light fixture Process for the continuous preparation of yogurt and other fermented milk products Chiral laser utilizing a quarter wave plate Incinerator with fluid-cooled hearth © 2006-2008 PatentGenius. All Rights Reserved.